Zinc toxicity

Revision as of 18:26, 28 September 2021 by Rossdonaldson1 (talk | contribs) (→‎References)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • Transition metal
  • Essential nutrient
  • Exposure from diet, medicinal uses, nutritional supplements, and occupational exposures
    • Multiple case reports of zinc toxicity related to ingestion of United States pennies which contain 97.5% zinc

Toxicokinetics

  • Absorbed primarily in the jejunum
  • Excreted via the GI tract with minimal amounts excreted in the urine
  • Accumulates in erythrocytes
    • Whole blood concentrations are 6-7x higher than in the serum
  • Inverse relationship with copper
    • Excess zinc absorption will cause a counterregulatory response resulting in copper elimination

Clinical Features

Acute

Chronic

Differential Diagnosis

Background

Heavy metal toxicity results from exposure to metals like lead, mercury, arsenic, or cadmium, which interfere with cellular function. Exposure may occur occupationally, environmentally, through ingestion, or from alternative medicines. Chronic toxicity can present insidiously, while acute toxicity may mimic sepsis or encephalopathy. Diagnosis is often delayed due to nonspecific symptoms.

Clinical Features

Symptoms depend on the metal and exposure duration but may include:

Neurologic: Peripheral neuropathy, confusion, tremor, encephalopathy

GI: Abdominal pain, nausea, vomiting, diarrhea, anorexia

Heme: Anemia (especially microcytic or hemolytic), basophilic stippling (lead)

Renal: Tubular dysfunction, proteinuria, Fanconi syndrome

Dermatologic: Mees’ lines (arsenic), hyperpigmentation, hair loss

Others: Fatigue, weight loss, hypertension (cadmium), immunosuppression

Differential Diagnosis

Sepsis or systemic inflammatory response

Drug toxicity or overdose

Metabolic disorders (e.g., porphyria, uremia)

Psychiatric illness (if symptoms are vague or bizarre)

Neurologic diseases (e.g., Guillain-Barré, MS, Parkinson’s)

Vitamin deficiencies (e.g., B12, thiamine)

Evaluation

Workup

History: Occupational exposures, home remedies, hobbies (e.g., jewelry making, battery recycling), diet, water source, imported goods

Labs:

  • CBC, CMP, urinalysis
  • Blood lead level, serum/urine arsenic, mercury, or cadmium (based on suspicion)
  • Urine heavy metal screen (note: spot testing may require creatinine correction)

Imaging: Abdominal X-ray (radiopaque material in GI tract, especially with lead)

EKG: Evaluate for QT prolongation or arrhythmias in severe cases

Diagnosis

Confirmed by elevated blood or urine levels of the specific metal in the context of clinical findings. Hair and nail testing are unreliable for acute toxicity. Interpret results with toxicologist input if possible.

Management

Remove the source of exposure (e.g., occupational control, GI decontamination if recent ingestion)

Supportive care: IV fluids, seizure control, electrolyte repletion

Chelation therapy (in consultation with toxicology or Poison Control):

Lead: EDTA, dimercaprol (BAL), succimer

Mercury/arsenic: Dimercaprol or DMSA

Cadmium: No effective chelation—focus on supportive care

Notify local public health authorities if exposure source is environmental or occupational

Disposition

Admit if symptomatic, unstable, or requiring chelation

Discharge may be appropriate for asymptomatic patients with low-level exposure and outpatient follow-up

Arrange toxicology or environmental medicine follow-up for source control and serial testing

See Also

Evaluation

  • BMP
  • CBC
  • Copper level
  • Ceruloplasmin level
  • Abdominal films to assess for foreign bodies
  • MRI
    • Will show increase T2 signal in the dorsal columns of the cervical cord

Management

  • Oral toxicity
  • Inhalation
  • Chelation
    • Limited data on use, and data present is based off of case reports and treatment for lead toxicity [1]
    • Consider in patients with hemodynamic compromise
    • CaNa2EDTA, British antilewisite, DTPA were all successfully used in case reports
    • 1000mg/m2/d IV CaNa2EDTA every 6 hours
      • Based on a successful case report, but should be given in conjunction with toxicology or poison control center
  • Dermal Exposures
    • Do not use water in metallic zinc exposures
      • Concern metal will ignite
    • Remove zinc with forceps and apply mineral oil to affected skin
  • Copper replacement
    • Oral copper alone shown to improve hematopoietic effects and prevent further neurological deterioration [2]

Disposition

References

  1. Majlesi, N. Zinc. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1342
  2. Rowin J, Lewis SL. Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry. 2005;76:750-751.